Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Current issues in the initial phase of warfarin therapy].

Alessandro Squizzato, Luigi Steidl, Walter Ageno

    Recenti Progressi in Medicina
    |February 25, 2006
    PubMed
    Summary

    Warfarin dosing requires careful management due to complex pharmacokinetics. Individualizing starting warfarin doses based on patient factors like age and health status improves safety and efficacy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical and Safety Outcomes of Patients Admitted to Different Specialty Wards: The Prospective, Multi-center, Controlled SISIFO Study.

    Journal of patient safety·2026
    Same author

    Robustness of placebo-controlled trials of extended-duration direct oral anticoagulant therapy for secondary venous thromboembolism prevention.

    Internal and emergency medicine·2026
    Same author

    Prescribing patterns and clinician preferences for direct oral anticoagulant use in unusual site venous thromboembolism: a cross-sectional analysis from the Direct oral anticoagulants in Unusual Site venous Thromboembolism (DUST) study.

    Research and practice in thrombosis and haemostasis·2026
    Same author

    Clinical and patient-reported outcomes after drug-coated balloon angioplasty for femoropopliteal peripheral artery disease.

    VASA. Zeitschrift fur Gefasskrankheiten·2026
    Same author

    Exploring Italian nursing staff in anticoagulation clinics: a cluster-based description of current practice, nurse self-efficacy, job satisfaction, and interprofessional collaboration.

    Internal and emergency medicine·2026
    Same author

    Endovascular reperfusion strategies for pregnancy-related pulmonary embolism: a systematic review.

    Journal of thrombosis and thrombolysis·2026

    Area of Science:

    • Pharmacology
    • Clinical Medicine
    • Thrombosis Research

    Background:

    • Warfarin is a widely used vitamin K antagonist (VKA) for preventing and treating thromboembolism.
    • Managing warfarin therapy presents challenges due to its complex pharmacokinetics and pharmacodynamics.
    • The unpredictable induction phase increases risks of bleeding or thrombosis.

    Discussion:

    • Several algorithms for initiating warfarin therapy have been developed but lack widespread acceptance.
    • Published clinical trials assessed various initial warfarin therapy approaches, highlighting findings and limitations.
    • Evidence supports using different starting warfarin doses based on individual and disease-specific factors.

    Key Insights:

    • Younger outpatients typically require higher starting warfarin doses (7.5-10 mg).
    • Older and hospitalized patients may need lower starting doses (2.5-5 mg).
    • Patients undergoing cardiopulmonary bypass surgery have specific warfarin dosing requirements.

    Outlook:

    • Further clinical studies are needed to optimize individualized warfarin initiation strategies.
    • Personalized warfarin dosing can enhance therapeutic outcomes and patient safety.
    • Continued research aims to refine warfarin management protocols for better anticoagulation control.

    Related Experiment Videos